Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 6MDT | 6MDT | Crystal structure of the B41 SOSIP.664 Env trimer with PGT124 and 35O22 Fabs, in P63 space group | |
| 6MEH | 6MEH | Crystal structure of broadly neutralizing antibody HEPC74 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | |
| 6MEI | 6MEI | Crystal structure of broadly neutralizing antibody HEPC3 in complex with Hepatitis C virus envelope glycoprotein E2 ectodomain | Polyprotein, HEPC3 Heavy Chain, HEPC3 Light Chain |
| 6MEJ | 6MEJ | Crystal structure of Hepatitis C virus envelope glycoprotein E2 ectodomain in complex with human antibodies HEPC3 and HEPC46 | |
| 6MEK | 6MEK | Crystal structure of Hepatitis C virus envelope glycoprotein E2 core in complex with human antibodies HEPC3 and HEPC46 | |
| 6MFF | 6MFF | HLA-DQ2-glia-omega1 | |
| 6MFF | 6MFF | HLA-DQ2-glia-omega1 | |
| 6MFG | 6MFG | HLA-DQ2-glia-alpha1 | |
| 6MFG | 6MFG | HLA-DQ2-glia-alpha1 | |
| 6MFJ | 6MFJ | Crystal structure of the ADCC potent antibody DH677.3 Fab elicited in the RV305 vaccine trial. | |
| 6MFP | 6MFP | Crystal Structure of the RV305 C1-C2 specific ADCC potent antibody DH677.3 Fab in complex with HIV-1 clade A/E gp120 and M48U1 | |
| 6MFT | 6MFT | Crystal structure of glycosylated 426c HIV-1 gp120 core G459C in complex with glVRC01 A60C heavy chain | |
| 6MG7 | 6MG7 | Crystal structure of the RV144 C1-C2 specific antibody CH54 Fab in complex with HIV-1 CLADE A/E GP120 and M48U1 | |
| 6MGQ | 6MGQ | ERAP1 in the open conformation bound to 10mer phosphinic inhibitor DG014 | |
| 6MHR | 6MHR | Structure of the human 4-1BB / Urelumab Fab complex | |
| 6MI2 | 6MI2 | Structure of the human 4-1BB / Utomilumab Fab complex | |
| 6MID | 6MID | Cryo-EM structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195 | |
| 6MID | 6MID | Cryo-EM structure of the ZIKV virion in complex with Fab fragments of the potently neutralizing human monoclonal antibody ZIKV-195 | |
| 6MIV | 6MIV | Crystal structure of the mCD1d/xxq (JJ300)/iNKTCR ternary complex | |
| 6MIV | 6MIV | Crystal structure of the mCD1d/xxq (JJ300)/iNKTCR ternary complex | |
| 6MIY | 6MIY | Crystal structure of the mCD1d/xxa (JJ239)/iNKTCR ternary complex | |
| 6MIY | 6MIY | Crystal structure of the mCD1d/xxa (JJ239)/iNKTCR ternary complex | |
| 6MJ4 | 6MJ4 | Crystal structure of MCD1D/INKTCR TERNARY COMPLEX bound to glycolipid (XXW) | |
| 6MJ4 | 6MJ4 | Crystal structure of MCD1D/INKTCR TERNARY COMPLEX bound to glycolipid (XXW) | |
| 6MJ6 | 6MJ6 | Crystal structure of the mCD1d/xxx (JJ166) /iNKTCR ternary complex | |
| 6MJ6 | 6MJ6 | Crystal structure of the mCD1d/xxx (JJ166) /iNKTCR ternary complex | |
| 6MJA | 6MJA | Crystal structure of the mCD1d/xxo (JJ294) /iNKTCR ternary complex | |
| 6MJA | 6MJA | Crystal structure of the mCD1d/xxo (JJ294) /iNKTCR ternary complex | |
| 6MJI | 6MJI | Crystal structure of the mCD1d/xxs (JJ304) /iNKTCR ternary complex | |
| 6MJI | 6MJI | Crystal structure of the mCD1d/xxs (JJ304) /iNKTCR ternary complex | |
| 6MJJ | 6MJJ | Crystal structure of the mCD1d/xxm (JJ290) /iNKTCR ternary complex | |
| 6MJJ | 6MJJ | Crystal structure of the mCD1d/xxm (JJ290) /iNKTCR ternary complex | |
| 6MJQ | 6MJQ | Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex | |
| 6MJQ | 6MJQ | Crystal structure of the mCD1d/xxp (JJ295) /iNKTCR ternary complex | |
| 6ML8 | 6ML8 | Crystal structure of hemagglutinin from H1N1 Influenza A virus A/Denver/57 bound to the C05 antibody | |
| 6MLM | 6MLM | H7 HA0 in complex with Fv from H7.5 IgG | |
| 6MN7 | 6MN7 | Cryo-EM structure of BG505.SOSIP.664 in complex with BF520.1 antigen binding fragment | |
| 6MNF | 6MNF | Anti-HIV-1 Fab 2G12 + Man8 re-refinement | |
| 6MPG | 6MPG | Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | |
| 6MPH | 6MPH | Cryo-EM structure at 3.8 A resolution of HIV-1 fusion peptide-directed antibody, DF1W-a.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122 | |
| 6MRV | 6MRV | Sialidase26 co-crystallized with DANA | |
| 6MSL | 6MSL | Integrin AlphaVBeta3 ectodomain bound to EETI-II 2.5D | |
| 6MSS | 6MSS | Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies | |
| 6MSU | 6MSU | Integrin alphaVBeta3 in complex with EETI-II 2.5F | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MSY | 6MSY | Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement | |
| 6MTJ | 6MTJ | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-378806 in Complex with Human Antibodies 3H109L and 35O22 at 2.9 Angstrom | |
| 6MTN | 6MTN | Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor Compound 484 in Complex with Human Antibodies 3H109L and 35O22 at 3.0 Angstrom | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement | |
| 6MU3 | 6MU3 | Anti-HIV-1 Fab 2G12 + Man7 re-refinement |
